Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online July 13, 2007
Diabetes Care 30:2523-2528, 2007
DOI: 10.2337/dc07-0282
© 2007 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online-Only Appendix
Right arrow All Versions of this Article:
dc07-0282v1
dc07-0282v2
30/10/2523    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Raile, K.
Right arrow Articles by Holl, R. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Raile, K.
Right arrow Articles by Holl, R. W.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Epidemiology/Health Services Research
Original Article

Diabetic Nephropathy in 27,805 Children, Adolescents, and Adults With Type 1 Diabetes

Effect of diabetes duration, A1C, hypertension, dyslipidemia, diabetes onset, and sex

Klemens Raile, MD1, Angela Galler, MD2, Sabine Hofer, MD3, Antje Herbst, MD4, Desiree Dunstheimer, MD5, Petra Busch, MD6 and Reinhard W. Holl, MD7

1 Department of Pediatric Endocrinology and Diabetes, Charité Children's Hospital, Berlin, Germany
2 Department of Pediatric Endocrinology and Diabetes, University Hospital for Children and Adolescents, Leipzig, Germany
3 Department of Pediatrics, Medical University of Innsbruck, Innsbruck, Austria
4 Department of Pediatric Diabetology, Children's Hospital, Leverkusen, Germany
5 Children's Hospital, Klinikum Augsburg, Ausburg, Germany
6 Department of Internal Medicine II, SLK-Kliniken Heilbronn, Heilbronn, Germany
7 Department of Epidemiology, University of Ulm, Ulm, Germany

Address correspondence and reprint requests to Klemens Raile, MD, Department of Pediatric Endocrinology and Diabetes, Charité Children's Hospital, Augustenburger Platz 1, 13353 Berlin, Germany. E-mail: klemens.raile{at}charite.de

OBJECTIVE—To give an up-to-date profile of nephropathy and the involvement of risk factors in a large, prospective cohort of patients with type 1 diabetes and largely pediatric and adolescent onset of disease.

RESEARCH DESIGN AND METHODS—A total of 27,805 patients from the nationwide, prospective German Diabetes Documentation System survey were included in the present analysis. Inclusion criteria were at least two documented urine analyses with identical classification. Urine analyses, treatment regimens, diabetes complications, and risk factors were recorded prospectively. Baseline characteristics were age at diagnosis 9.94 years (median [interquartile range 5.8–14.3]), age at last visit 16.34 years (12.5–22.2), and follow-up time 2.5 years (0.43–5.3). Cumulative incidence of nephropathy was tested by Kaplan-Meier analysis and association with risk factors by logistic regression.

RESULTS—Nephropathy was classified as normal in 26,605, microalbuminuric in 919, macroalbuminuric in 78, and end-stage renal disease (ESRD) in 203 patients. After calculated diabetes duration of 40 years, 25.4% (95% CI 22.3–28.3) had microalbuminuria and 9.4% (8.3–11.4) had macroalbuminuria or ESRD. Risk factors for microalbuminuria were diabetes duration (odds ratio 1.033, P < 0.0001), A1C (1.13, P < 0.0001), LDL cholesterol (1.003, P < 0.0074), and blood pressure (1.008, P < 0.0074), while childhood diabetes onset (1.011, P < 0.0001) was protective. Male sex was associated with the development of macroalbuminuria.

CONCLUSIONS—Diabetes duration, A1C, dyslipidemia, blood pressure, and male sex were identified as risk factors for nephropathy. Therefore, besides the best possible metabolic control, early diagnosis and prompt treatment of dyslipidemia and hypertension is mandatory in patients with type 1 diabetes.

Abbreviations: AER, albumin excretion rate • DCCT, Diabetes Control and Complications Trial • DPV, German Diabetes Documentation System • ESRD, end-stage renal disease


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
HypertensionHome page
L. L. Yanes, J. C. Sartori-Valinotti, and J. F. Reckelhoff
Sex Steroids and Renal Disease: Lessons From Animal Studies
Hypertension, April 1, 2008; 51(4): 976 - 981.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.